American Society of Nephrology

And thanks, Kyle.

This podcast is copyrighted by the American Society of Nephrology.

All rights reserved.

All content in this podcast is for informational purposes only and is not intended to be medical advice.

This podcast should not be used in a medical emergency or for the diagnosis or treatment of any medical condition.

Please consult your doctor or other qualified healthcare professional if you have any questions about any medical condition or before taking any drug, changing your diet, or commencing or discontinuing any course of treatment.

Thank you for listening to this podcast from the American Society of Nephrology.

Thank you again, C. Jason readers, for tuning in, and we look forward to having you join us again next month.

This podcast is copyrighted by the American Society of Nephrology.

All rights reserved.

All content in this podcast is for informational purposes only and is not intended to be medical advice.

This podcast should not be used in a medical emergency or for the diagnosis or treatment of any medical condition.

Please consult your doctor or other qualified healthcare professional if you have any questions about any medical condition or before taking any drug, changing your diet, or commencing or discontinuing any course of treatment.

Thank you for listening to this podcast from the American Society of Nephrology.

If you have any questions about any medical conditions or before or taking any drug, changing your diet, or commencing or discontinuing any course of treatment.

Thank you for listening to this podcast by the American Society of Nephrology.

Well, Lauren and I are excited to have a conversation around the new, the sort of updated 2.0 toolkit for EGFR.

And this really builds off the work that you helped lead with the National Kidney Foundation and ASN related to removing race from how we assess kidney function.

So maybe if you could just provide some background about the partnership between ASN and NKF, and we can kind of set the table there and kind of talk about the updated toolkit.

Yeah.

So if we sort of trace back to 2020, which of course was a time when all of us were dealing with the pandemic and also observing a lot of disparities and inequities that were really kind of coming to the forefront during that time, there was an increase in calls for re-examining the way that we estimate kidney function, right, with the fact that for the last, for the prior two decades, the equation that we'd used included a coefficient for black race.

And I should say that even though there, in 2020, there were these interesting increases in those sort of calls.

There had been some people that had written about this issue, but I think the topic got a lot more attention in 2020.

And then, as you mentioned, of course, ASN and NKF partnered to establish a task force to take a look at the equation.

[outro music]

This podcast is copyrighted by the American Society of Nephrology.

All rights reserved.

All content in this podcast is for informational purposes only and is not intended to be medical advice.

This podcast should not be used in a medical emergency or for the diagnosis or treatment of any medical condition.

Please consult your doctor or other qualified healthcare professional if you have any questions about any medical condition or before taking any drug, changing your diet, or commencing or discontinuing any course of treatment.

Thank you for listening to this podcast from the American Society of Nephrology.

[outro music]

The number one cause of death, of course, is cardiovascular disease, and even more so for kidney patients.

Welcome to the ASN Kidney Translation Podcast.

I'm your host, Dr. Matthew Sparks, and today we have another issue of the ASN Kidney Health Guidance, this one on cardiovascular kidney metabolic syndrome, or CKM syndrome.

We have two authors of that document.

We have Dr. Nisha Bansal from the University of Washington and Dr. Alex Chang from Geisinger.

This is Alex Chang.

I'm a nephrologist at Geisinger Health and wonderful to be here.

We've had several of these, the ASN kidney health guidance.

Thank you so much, Sreenath.

I really want to take a moment to thank you and the American Society of Nephrology for having me as your guest on the podcast today.

I'm grateful for the opportunity to share my experiences both as a wildfire survivor and as a nephrologist and medical director during that very difficult time for our community.

It really serves as a strong personal reminder for me of the critical importance of disaster preparedness.

Please join us for part two.

Thank you.

This podcast is copyrighted by the American Society of Nephrology, all rights reserved.

All content in this podcast is for informational purposes only and is not intended to be medical advice.